03.14.26 -- Clinical Leader Best Of February

A collaboration between Tufts CSDD, Tufts School of Medicine, and TransCelereate BioPharma revealed just how much extra data sponsors are collecting — and why that's a problem.

Digital protocols could reduce manual effort and enable rapid and more consistent downstream study execution, reporting, and submission processes.

On December 15, 2025, the FDA finalized its guidance Enhancing Participation in Clinical Trials, formally updating expectations for enrollment and trial design. Here's what you can do now.

Examine the current state of RBQM approaches to virtualizing clinical oversight, and the value that adopting these approaches brings to sponsors, CROs, sites, and ultimately patients.

Discover how digital innovation and patient-centric technologies are reshaping clinical trials by improving access, efficiency, and data-driven insights.

Obesity trials face high dropout rates due to long durations and complex requirements. Overcome these hurdles with personalized engagement, expert lifestyle support, and proactive patient care.